Shares of Biogen (BIIB) and Eli Lilly (LLY) were both moving as they reported data on their key drug candidates for Alzheimer’s disease Wednesday, while Wall Street debated the meaning of the results. Biogen’s aducanumab was the particular focus of attention. At the Alzheimer’s Association International Conference (AAIC), the company reported the effects of aducanumab on patients with mild or prodromal (i.e. even earlier than mild) Alzheimer’s
With federal regulators poised to approve AT&T ‘s (T) acquisition of DirecTV Group (DTV), the Q2 earnings estimates of both companies have a low bar heading into the merger. AT&T, which reports Q2 earnings after the market close Thursday, is expected to report EPS growth of 2% and revenue growth of 1%, according to analysts polled by Thomson Reuters. DirecTV would normally report Q2 earnings the first week of August, but the merger might close
The strong box office performances of “Jurassic World” and “Pitch Perfect 2” are expected to boost results at NBCUniversal, though weaker advertising trends and a seasonally weak quarter for the cable TV business will also affect Comcast’s (CMCSA) Q2 earnings, analysts say. Comcast reports Q2 earnings before the market opens Thursday. Comcast’s Q2 EPS is expected to rise 11% from Q2 2014, to 84 cents per share, with revenue up 8% to $8.14 billion,